TY  - GEN
AU  - Sharma, Aruna
AU  - Sharma, Hari Shanker
TI  -  Nanoneuroprotection and nanoneurotoxicology; volume 245
SN  - 9780444642080
AV  - RC347.5 SHA 2019
PY  - 2019///
CY  - Cambridge
PB  - Academic Press
KW  -  Agents neuroprotecteurs
KW  - Drug Delivery Systems
KW  - HEALTH & FITNESS Diseases General
KW  - MEDICAL Clinical Medicine
KW  - MEDICAL Diseases
KW  - MEDICAL Evidence-Based Medicine
KW  - MEDICAL Internal Medicine
KW  - Nervous System Diseases
KW  - Nervous system Diseases
KW  - Neuroprotection
KW  - Neuroprotective Agents
KW  - Neuroprotective Agents therapeutic use
KW  - Neuroprotective agents
KW  -  Neurotoxicologie
KW  - Neurotoxicology
KW  - Neurotransmitter Agents therapeutic use
N1  - volume 245; Includes bibliographical references; Front Cover; Nanoneuroprotection and Nanoneurotoxicology; Copyright; Contributors; Contents; Preface; References; Acknowledgments; Chapter 1: Sleep deprivation exacerbates concussive head injury induced brain pathology: Neuroprotective effects of nano ... ; 1. Introduction; 1.1. Sleep deprivation and neurological diseases; 1.1.1. Sleep deprivation and cerebrovascular disease; 1.1.2. Alzheimer's disease; 1.1.3. Parkinson's disease; 1.1.4. Epilepsy; 1.1.5. Headache and related disorders; 1.2. Sleep disturbances and traumatic brain injuries 3.2.1. Circulating BDNF in clinical traumatic brain injuries 4. Cerebrolysin and traumatic brain injuries; 4.1. Cerebrolysin and preclinical studies on TBI; 4.2. Cerebrolysin in clinical TBI; 5. Nanodelivery of drugs induce superior neuroprotection; 6. Our own investigations on SD and TBI; 6.1. Methodological consideration; 6.1.1. Methods to induce SD; 6.1.2. Concussive head injury; 6.2. Parameters measured; 6.2.1. Blood-brain barrier permeability; 6.2.2. Brain edema formation and volume swelling; 6.2.3. Brain pathology; 6.3. Biochemical measurements
N2  - Nanoneuroprotection and Nanoneurotoxicology, Volume 245 of the Progress in Brain Research series, deals with recent developments in the field of neurotoxicity and neuroprotection using nanobiotechnology for the first time. Chapters in this updated release include Sleep deprivation induced brain pathology and concussive head trauma-Neuroprotective effects of nanowired delivery of drugs and hormones, Nanomedicine in Alzheimer's Disease: amyloid beta targeting strategy, How traumatic brain injury alters amino acids balance in the central nervous system-Neuroprotection by TiO2 nanowired delivery of drugs and antibodies, Nanowired delivery of DL-3-n-butylphthalide and neuroprotection in concussive head injury, Nanodelivery of drugs and antibodies for superior neuroprotection in Alzheimer's disease, and more. Key Features: Highlights recent development in nanopharmacetical research with reference to brain disease; Provides new insights on the possible role of nanomaterials and their pronounced effects on CNS injury or repair. Readership: Researchers and students of neuroscience, psychology, and the biological sciences interested in nanoneuroprotection and nanoneurotoxicology. -- Provided by publisher
ER  -